Jenscare Scientific Co., Ltd (HKG: 9877), a Ningbo-based structural heart disease device maker, has announced receiving marketing approval from the National Medical Products Administration (NMPA) for its transcatheter artificial aortic valve system Ken Valve. The company is now preparing for the commercialization of the product.
Product Design and Advantages
The in-house developed Ken Valve is designed for patients with aortic regurgitation or concomitant aortic stenosis. Its multi-specification design and large size are expected to cover a wide range of patient populations. The valve features an integrated positioning key design for stable anchoring and a leak-proof ring to reduce postoperative perivalvular leakage. Additionally, the adjustable bending conveyor system is designed to shorten the surgeon’s learning curve and improve intraoperative efficiency.-Fineline Info & Tech
Leave a Reply